English: Can I thank Altaf for giving me a minute of his time? As chair of the cross-party group on liver disease and liver cancer, I want to highlight some of the challenges facing liver cancer patients navigating treatment pathways in Wales. Liver cancer is one of the least survivable, but fastest growing forms of cancer in the UK, and outcomes are shockingly poor. Only 13 per cent of people diagnosed with liver cancer will survive for more than five years after being diagnosed. It has been found that patients with low fitness, as assessed by the cardiopulmonary exercise testing, CPET, have higher mortality and morbidity after surgery. Therefore, prehabilitation has potential as a method to improve CPET values and thus improve outcomes after liver resection for colorectal or liver metastatic. It has also been found to better prepare patients for the often toxic and disabling effects of cancer treatment. Recent findings from the British Liver Trust's helpline, support groups and surveys show that fewer than 10 per cent of liver cancer patients feel adequately signposted to information about their condition, and many are left confused and unsure of where to go for credible advice on treatment options. There are also disparities in liver cancer care and outcomes across health boards. Therefore, improving access to rehabilitation, personalised information and ensuring equitable access to physical, psychological and nutritional support for liver cancer patients at every stage of the treatment pathway will not only improve patient experience, but, ultimately, could improve outcomes and survival rates for liver cancer patients. With this in mind, I'm keen to know if the Minister will commit to specific targets for prehabilitation and rehabilitation to help improve outcomes for less survivable cancers, such as liver cancer, in the forthcoming NHS cancer services action plan. Thank you.
Welsh: A gaf fi ddiolch i Altaf am roi munud o'i amser i mi? Fel cadeirydd y grŵp trawsbleidiol ar glefyd yr afu a chanser yr afu, rwyf am dynnu sylw at rai o'r heriau sy'n wynebu cleifion canser yr afu wrth iddynt lywio llwybrau triniaeth yng Nghymru. Mae canser yr afu yn un o'r mathau mwyaf anodd i'w goroesi, ond mae ymhlith y mathau o ganser sy'n tyfu gyflymaf yn y DU, ac mae'r canlyniadau'n frawychus o wael. Dim ond 13 y cant o bobl a gaiff ddiagnosis o ganser yr afu a fydd yn goroesi am fwy na phum mlynedd ar ôl cael diagnosis. Canfuwyd bod cleifion y mae eu lefelau ffitrwydd yn isel, fel y'u haseswyd drwy brofion ymarfer cardio-pwlmonaidd, CPET, â chyfraddau marwolaethau ac afiachedd uwch ar ôl llawdriniaeth. Felly, mae potensial i ragsefydlu fel dull o wella gwerthoedd CPET ac felly, i wella canlyniadau ar ôl echdorri'r afu ar gyfer canser metastatig y colon a'r rhefr neu'r afu. Canfuwyd hefyd ei fod yn paratoi cleifion yn well ar gyfer effeithiau triniaeth ganser sy'n aml yn wenwynig ac yn anablu. Mae canfyddiadau diweddar gan linell gymorth, grwpiau cymorth ac arolygon Ymddiriedolaeth Brydeinig yr Afu yn dangos bod llai na 10 y cant o gleifion canser yr afu yn teimlo eu bod wedi'u cyfeirio'n ddigonol at wybodaeth am eu cyflwr, ac mae llawer yn cael eu gadael yn ddryslyd ac yn ansicr ynglŷn â lle i ofyn am gyngor credadwy ar opsiynau triniaeth. Ceir gwahaniaethau hefyd o ran gofal a chanlyniadau canser yr afu ar draws y byrddau iechyd. Felly, bydd gwella mynediad at adsefydlu, gwybodaeth wedi'i phersonoli a sicrhau mynediad teg at gefnogaeth gorfforol, seicolegol a maethol i gleifion canser yr afu ar bob cam o'r llwybr triniaeth nid yn unig yn gwella profiad cleifion, ond yn y pen draw, gallai wella canlyniadau a chyfraddau goroesi i gleifion canser yr afu. Gyda hyn mewn golwg, rwy'n awyddus i wybod a wnaiff y Gweinidog ymrwymo i dargedau penodol ar gyfer rhagsefydlu ac adsefydlu i helpu i wella canlyniadau ar gyfer canserau anos eu goroesi, fel canser yr afu, yng nghynllun gweithredu gwasanaethau canser y GIG sydd ar y ffordd. Diolch.